Consumer

From Porsche to Carlsberg and JetBlue, Tariff Toll Spreads

AstraZeneca posted higher profit in the first quarter, driven by sales of its diabetes and cancer medicines. The British drugmaker confirmed its guidance for the year and also said it was committed to investing and growing in the US as the industry braces for tariffs. AstraZeneca CEO speaks on Bloomberg TV’s Guy Johnson, Kriti Gupta and Anna Edwards.Source: Bloomberg
Lock
This article is for subscribers only.

Companies around the world including carmakers, brewers, airlines and packaged food makers are sounding a warning that US President Donald Trump’s import tariffs are beginning to wreak havoc on their businesses.

For some, the levies are squeezing margins, weighing on sales and prompting often costly efforts to shift production to the US. For others, the main concern is the impact on the global economy. For nearly all, uncertainty around the eventual level of duties is making effective forecasting almost impossible.